Skip to content

Analysis of changes in blood pressure, rSO2, and cerebral hemodynamics in hypertensive patients during anesthesia induction

Analysis of changes in blood pressure, rSO2, and cerebral hemodynamics in hypertensive patients during anesthesia induction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088502
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-08-20
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive impairment and perioperative stroke

Interventions

Group N:Adjust the infusion rates of propofol and remifentanil during anesthesia induction to reduce mean arterial pressure (MAP) by 25% and 35% of baseline MAP
Group HL:Adjust the infusion rates of propofol and remifentanil during anesthesia induction to reduce mean arterial pressure (MAP) by 25% and 35% of baseline MAP
Group HM:Adjust the infusion rates of propofol and remifentanil during anesthesia induction to reduce mean arterial pressure (MAP) by 25% and 35% of baseline MAP
Group HH:Adjust the infusion rates of propofol and remifentanil during anesthesia induction to reduce mean arterial pressure (MAP) by 25% and 35% of baseline MAP

Sponsors

The First Affiliated Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-75 years old 2. Patients undergoing general anesthesia surgery 3. American Society of Anesthesiologists (ASA): ?-? 4. Surgery for patients in supine position

Exclusion criteria

Exclusion criteria: 1.Serious history of heart and cerebrovascular disease (frequent atrial fibrillation or premature ventricular contractions, heart failure, intracranial hypertension, epilepsy, new myocardial infarction and cerebral infarction in the past six months, etc.) 2.Pulmonary diseases and severe liver and kidney diseases (such as chronic obstructive pulmonary disease, uremia, cirrhosis, etc.) 3.Patients who require heart, lung, and cerebrovascular related surgeries

Design outcomes

Primary

MeasureTime frame
Mean blood flow velocity of middle cerebral artery,Vm;Cerebral oxygen saturation,rSO2;

Secondary

MeasureTime frame
Mean arterial pressure, MAP;

Countries

China

Contacts

Public ContactWenjun Guo

The First Affiliated Hospital of Wannan Medical College

1527164265@qq.com+86 178 5691 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026